TrialClinical cancer research : an official journal of the American Association for Cancer Research2026

First-line Anlotinib plus Anthracyclines and Ifosfamide Followed by Anlotinib Maintenance in Advanced Soft-Tissue Sarcoma: A Phase II Single-Arm Trial.

Jun-Kai Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.